Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease.

Paulin LM, Diette GB, Blanc PD, Putcha N, Eisner MD, Kanner RE, Belli AJ, Christenson S, Tashkin DP, Han M, Barr RG, Hansel NN; SPIROMICS Research Group.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):557-65. doi: 10.1164/rccm.201408-1407OC.

PMID:
25562375
2.

Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).

Smith BM, Hoffman EA, Rabinowitz D, Bleecker E, Christenson S, Couper D, Donohue KM, Han MK, Hansel NN, Kanner RE, Kleerup E, Rennard S, Barr RG.

Thorax. 2014 Nov;69(11):987-96. doi: 10.1136/thoraxjnl-2014-205160. Epub 2014 Jun 13.

3.

Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.

O'Neal WK, Anderson W, Basta PV, Carretta EE, Doerschuk CM, Barr RG, Bleecker ER, Christenson SA, Curtis JL, Han MK, Hansel NN, Kanner RE, Kleerup EC, Martinez FJ, Miller BE, Peters SP, Rennard SI, Scholand MB, Tal-Singer R, Woodruff PG, Couper DJ, Davis SM; SPIROMICS Investigators.

J Transl Med. 2014 Jan 8;12:9. doi: 10.1186/1479-5876-12-9.

4.

[Open letter to the members of the GOLD committee].

Le groupe Pulmonaria, Quanjer PH, Enright PL, Stocks J, Ruppel G, Swanney MP, Crapo RO, Pedersen OF, Falaschetti E, Schouten JP, Jensen RL; ANZSRS : Australian and New Zealand Society of Respiratory; ARTP : Association for Respiratory Technology and Physiology; CAHAG : COPD and Astma Huisartsen Advies Groep (COPD and Asthma GP Advisory Group); SKL : Dutch Paediatric Repiratory Society; Education for Health, Warwick, UK; National Respiratory Training Center, Virginia, US; NHG : Nederlands Huisartsen Genootschap (Dutch Society of GPs); NVALT : Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose (Dutch Thoracic Society); NVLA : Nederlandse Vereniging Longfunctie Analisten (Dutch Society of Respiratory Technicians); PCRS-UK : Primary Care Respiratory Society UK; Société de Physiologie; SPLF : Société de pneumologie de langue franc¸aise; SSMG : Société scientifique de médecine générale; WONCA: World Organization of Family Doctors.

Rev Mal Respir. 2010 Nov;27(9):1003-7. doi: 10.1016/j.rmr.2010.09.007. Epub 2010 Oct 8. French. No abstract available.

5.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

6.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
7.

Spirometry.

Liou TG, Kanner RE.

Clin Rev Allergy Immunol. 2009 Dec;37(3):137-52. doi: 10.1007/s12016-009-8128-z. Epub 2009 Apr 4. Review.

PMID:
19347610
8.

Measurement of lung volumes.

Liou TG, Kanner RE.

Clin Rev Allergy Immunol. 2009 Dec;37(3):153-8. doi: 10.1007/s12016-009-8127-0. Epub 2009 Apr 2.

PMID:
19337866
9.

Pulmonary function testing in the evaluation of patients with allergic and immunologic disorders.

Kanner RE.

Clin Rev Allergy Immunol. 2009 Dec;37(3):135-6. doi: 10.1007/s12016-009-8124-3. Epub 2009 Mar 13. No abstract available.

PMID:
19280370
10.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

11.

A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction.

Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N, Singh NA, Baird L, Coon H, McMahon WM, Piper ME, Fiore MC, Scholand MB, Connett JE, Kanner RE, Gahring LC, Rogers SW, Hoidal JR, Leppert MF.

PLoS Genet. 2008 Jul 11;4(7):e1000125. doi: 10.1371/journal.pgen.1000125.

13.

Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials.

Herpel LB, Kanner RE, Lee SM, Fessler HE, Sciurba FC, Connett JE, Wise RA; National Emphysema Treatment Trial Research Group.

Am J Respir Crit Care Med. 2006 May 15;173(10):1106-13. Epub 2006 Feb 23.

14.

Bronchodilator response in the lung health study over 11 yrs.

Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE; Lung Health Study Research Group.

Eur Respir J. 2005 Jul;26(1):45-51.

15.

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group.

Ann Intern Med. 2005 Feb 15;142(4):233-9.

PMID:
15710956
16.

Loss of bone density with inhaled triamcinolone in Lung Health Study II.

Scanlon PD, Connett JE, Wise RA, Tashkin DP, Madhok T, Skeans M, Carpenter PC, Bailey WC, Buist AS, Eichenhorn M, Kanner RE, Weinmann G; Lung Health Study Research Group.

Am J Respir Crit Care Med. 2004 Dec 15;170(12):1302-9. Epub 2004 Sep 16.

PMID:
15374846
17.

The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study.

Wise RA, Kanner RE, Lindgren P, Connett JE, Altose MD, Enright PL, Tashkin DP; Lung Health Study Research Group.

Chest. 2003 Aug;124(2):449-58.

PMID:
12907528
18.

Further evidence for the role of genes on chromosome 2 and chromosome 5 in the inheritance of pulmonary function.

Malhotra A, Peiffer AP, Ryujin DT, Elsner T, Kanner RE, Leppert MF, Hasstedt SJ.

Am J Respir Crit Care Med. 2003 Sep 1;168(5):556-61. Epub 2003 Jun 5.

PMID:
12791583
19.

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

Kanner RE, Anthonisen NR, Connett JE; Lung Health Study Research Group.

Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64.

PMID:
11500333
20.

Acute exposure to environmental tobacco smoke and heart rate variability.

Pope CA 3rd, Eatough DJ, Gold DR, Pang Y, Nielsen KR, Nath P, Verrier RL, Kanner RE.

Environ Health Perspect. 2001 Jul;109(7):711-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk